Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1975 Jul;150(1):129–132. doi: 10.1042/bj1500129

Specific binding sites for 5-hydroxytryptamine on rat blood platelets.

A H Drummond, J L Gordon
PMCID: PMC1165712  PMID: 1201004

Abstract

5-Hydroxytryptamine changes the shape of rat blood platelets by combination with a cinanserin-sensitive receptor which is not associated with the active uptake of 5-hydroxytryptamine. Binding of 5-hydroxy[3H]tryptamine to platelets at 4 degrees C demonstrates the presence of three saturable sites, and the highest-affinity site is apparently this 5-hydroxytryptamine receptor.

Full text

PDF
129

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumgartner H. R. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets. J Physiol. 1969 Apr;201(2):409–423. doi: 10.1113/jphysiol.1969.sp008763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baumgartner H. R., Born G. V. Effects of 5-hydroxytryptamine on platelet aggregation. Nature. 1968 Apr 13;218(5137):137–141. doi: 10.1038/218137a0. [DOI] [PubMed] [Google Scholar]
  3. Baumgartner H. R., Born G. V. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets. J Physiol. 1969 Apr;201(2):397–408. doi: 10.1113/jphysiol.1969.sp008762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Born G. V., Juengjaroen K., Michal F. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues. Br J Pharmacol. 1972 Jan;44(1):117–139. doi: 10.1111/j.1476-5381.1972.tb07244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DOMENJOZ R., THEOBALD W. [On the pharmacology of tofranil (N-(3-dimethylaminopropyl)-iminodibenzyl hydrochloride]. Arch Int Pharmacodyn Ther. 1959 Jul 1;120:450–489. [PubMed] [Google Scholar]
  6. Drummond A. H., Gordon J. L. Letter: Rapid, sensitive microassay for platelet 5HT. Thromb Diath Haemorrh. 1974 May 15;31(2):366–367. [PubMed] [Google Scholar]
  7. Gordon J. L., Drummond A. H. A simple fluorimetric microassay for adenine compounds in platelets and plasma and its application to studies on the platelet release reaction. Biochem J. 1974 Feb;138(2):165–169. doi: 10.1042/bj1380165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MITCHELL J. R., SHARP A. A. PLATELET CLUMPING IN VITRO. Br J Haematol. 1964 Jan;10:78–93. doi: 10.1111/j.1365-2141.1964.tb00681.x. [DOI] [PubMed] [Google Scholar]
  9. O'Brien J. R., Heywood J. B. Effect of aggregating agents and their inhibitors on the mean platelet shape. J Clin Pathol. 1966 Mar;19(2):148–153. doi: 10.1136/jcp.19.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. RUBIN B., PIALA J. J., BURKE J. C., CRAVER B. N. A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS. Arch Int Pharmacodyn Ther. 1964 Nov 1;152:132–143. [PubMed] [Google Scholar]
  11. Sneddon J. M. Blood platelets as a model for monoamine-containing neurones. Prog Neurobiol. 1973;1(2):151–198. doi: 10.1016/0301-0082(73)90019-1. [DOI] [PubMed] [Google Scholar]
  12. Wong D. T., Horng J. S., Bymaster F. P., Hauser K. L., Molloy B. B. A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci. 1974 Aug 1;15(3):471–479. doi: 10.1016/0024-3205(74)90345-2. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES